Applications of Biosensors in Healthcare : Volume 3.

Format:

Book

Author/Creator:

Hasnain, Saquib.

Contributor:

Nayak, Amit Kumar.

Aminabhavi, Tejraj M.

Language:

English

Subjects (All):

Biosensors.

Medical technology.

Physical Description:

1 online resource (816 pages)

Edition:

1st ed.

Place of Publication:

Chantilly : Elsevier Science & Technology, 2025.

Summary:

Applications of Biosensors in Healthcare: Volume 3 details and explores the various ways biosensors are used in healthcare, disease management, and therapeutic delivery.This is the third volume out of three volumes covering biosensors in healthcare.

Contents:

Front Cover

APPLICATIONS OF BIOSENSORS IN HEALTHCARE

APPLICATIONS OF BIOSENSORS IN HEALTHCAREVOLUME 3EDITED BYMD SAQUIB HASNAINMARWADI UNIVERSITY RESEARCH CENTER, MARWADI UNIVE ...

Copyright

Contents

Contributors

Preface

1 - Biosensors in medical devices

1. Introduction

2. Medical device and biosensor

3. How can biosensors be integrated into medical devices?

4. Kinds of biosensors in medical devices

5. Current use of biosensors in medical devices in clinical medicine

6. Quality control and standardization for biosensors in medical devices in clinical medicine

7. Limitations for biosensors in medical devices in clinical medicine

8. Future trends for biosensors in medical devices in clinical medicine

9. Conclusion

References

2 - Biosensors as emerging tools in cancer theranostics: Recent progress

2. Biosensors as efficient diagnostics tools: basic principle and application

2.1 Molecular recognition element

2.2 Transducers

3. Types of biosensors

3.1 Electrochemical biosensors

3.2 Optical biosensor

3.3 Enzyme biosensors

3.4 Colorimetric biosensors

4. Cancer biomarkers and their significance in disease prognosis

4.1 Breast cancer

4.2 Prostate cancer

4.3 Colorectal cancer

4.4 Lung cancer

5. Recent theranostic applications of biosensors in cancer

6. Challenges in applications of biosensors

6.1 Sensitivity analysis

6.2 Continual in vivo monitoring

7. Integration and commercialization of biosensing device

8. Sustainability to the ecosystem

Acknowledgments

Disclosure statement

3 - Recent developments in biosensor based transdermal drug delivery systems

2. Understanding of basic structure of human skin

3. Overview of transdermal drug delivery systems.

3.1 Drug delivery mechanism

4. Biosensors

5. Bioresponsive TDDS

5.1 Classification of biosensors

5.2 Classification based on advancements in drug delivery, there are several other types of biosensor-based TDDS

6. Applications of biosensor-based TDDS

6.1 Pain management

6.2 Diabetes

6.2.1 Optical glucose sensors

6.2.2 Enzyme-based electrochemical sensors

6.2.3 Glucose dehydrogenase-based sensors

6.2.4 Nonenzymatic sensors

6.3 Obesity

6.4 Tumor and cancer

6.5 Neurological disorders

6.6 Topical diseases

6.7 Hormone replacement therapy

6.8 Wound healing

6.9 Miscellaneous

7. Conclusions

4 - Biosensors for targeted therapeutics

2. Principles of biosensors

2.1 Components of biosensors

2.2 Working mechanisms of biosensors

2.3 Types of biosensors used in targeted therapeutics

2.3.1 Optical biosensors

2.3.2 Electrochemical biosensors

2.3.3 Piezoelectric biosensors

2.3.4 Thermal biosensors

2.3.4.1 Uses of a thermal biosensor in targeted therapy

2.3.5 Magnetic biosensor

2.3.5.1 Uses of a magnetic biosensor in targeted therapy

3. Applications of biosensors in targeted therapeutics

4. Challenges and future perspectives

5. Conclusion

Funding

Conflict of interests

5 - Biosensors used for anticancer therapeutics

2. Biosensor fundamentals

2.1 Types of biosensors

2.1.1 Electrochemical biosensors

2.1.2 Optical biosensors

2.1.3 Mass-based biosensors

3. Biomarkers in anticancer biosensing

4. Biosensors for early cancer diagnosis

5. Conclusion and future perspective

6 - Biosensors for pulmonary drug delivery

2. Pulmonary drug delivery and associated barriers

3. Biosensor-based pulmonary drug delivery systems.

4. Smart microelectromechanical system (MEMS)-based drug delivery

5. Electrochemical sensors-based drug delivery

6. Stimuli responsive biopolymers

7. Conclusions and future prospective

7 - Biosensors used for minimally invasive drug delivery monitoring

2. Drug delivery methods

2.1 Invasive methods for drug delivery

2.1.1 Parenteral drug delivery

2.1.2 Subcutaneous

2.1.3 Intramuscular injections

2.1.4 Intravenous administration

2.1.5 Intra-arterial

2.2 Noninvasive methods for drug delivery

2.2.1 Transdermal drug delivery

2.2.2 Oral drug delivery

2.2.3 Inhalation delivery

2.2.4 Nasal drug delivery

2.2.5 Buccal drug delivery

2.3 Minimally invasive methods of drug delivery

3. Materials used to fabricate biosensors in drug delivery monitoring systems

3.1 Metal-organic frameworks

3.2 Polymers

3.3 Nanomaterials

4. Biosensor-based devices for drug delivery

4.1 Transdermal patches

4.2 Microneedles

4.3 DNA-based biosensors

4.4 Wearable biosensors

4.5 Iontophoresis-based biosensors

4.6 Cell-penetrating peptides

5. Type of samples

5.1 Saliva-based sensors

5.2 Tear-based sensors

5.3 Sweat-based sensors

5.4 Breath sensors

6. Biosensor-based technologies for noninvasive drug delivery monitoring

6.1 Optical biosensor-based drug delivery monitoring

6.1.1 Spectrophotometry

6.1.2 Fluorimetry

6.1.3 Surface-enhanced Raman scattering

6.1.4 Surface plasmon resonance spectroscopy

6.1.5 Chemiluminescence

6.1.6 Total internal reflection fluorescence spectroscopy

6.2 Electrochemical biosensor for drug delivery monitoring

6.2.1 Microneedle-based electrochemical biosensors

6.2.2 Pencil-graphite-based electrochemical biosensors

6.2.3 Field-effect transistor-based electrochemical biosensors.

6.2.4 Printed electrode-based electrochemical biosensor

7. Treatment of diseases using biosensors

7.1 Parkinson disease

7.2 Cancer

7.3 Diabetes

7.4 Cardiovascular diseases

7.5 Respiratory diseases

8. Current challenges and future prospects

Further readings

8 - Biosensors for protein and peptide delivery

2. Proteins and peptides as molecule recognition elements

2.1 Peptide-based protein sensors

2.2 Protein and peptide-based metallic ion sensors

2.3 Protein and peptide-based nucleic acid and other sensor types

3.1 Optical biosensors

3.2 Electrochemical biosensors

3.3 Mass-based biosensors

3.4 Magnetic biosensors

3.5 Thermal biosensors

3.6 Microfluidic biosensors

4. Design of protein and peptide-based biosensors

5. Applications of protein and peptide-based biosensors

6. Latest developments in the applications of (bio)sensors methods for detection of important analytes in real samples

7. Challenges and future directions

8. Conclusion

9 - Biosensors for detection of hormones and growth factors

2. Overview of hormones and growth factors

2.1 Hormones

2.2 Growth factors

3. Biosensors for detection of hormones

3.1 Pancreatic hormones

3.1.1 Insulin

3.1.1.1 Insulin pumps

3.2 Thyroid hormones

3.2.1 T3 and T4

3.2.2 PTH

3.2.3 Procalcitonin and calcitonin

3.3 Sex hormones

3.3.1 Estrogen

3.3.2 Progesterone

3.3.3 Testosterone

3.4 Adrenal hormones

3.4.1 Cortisol

3.4.2 Aldosterone

3.4.3 Adrenaline (epinephrine)

3.4.4 Norepinephrine

3.5 Hypothalamus

3.5.1 Dopamine

3.5.2 Somatostatin

3.5.3 Vasopressin

3.6 Pituitary glands

3.6.1 LH, FSH, ACTH, TSH

3.6.2 Oxytocin

3.6.3 Prolactin

3.7 Pineal

3.7.1 Melatonin.

4. Biosensors for detection of growth factors

4.1 Vascular endothelial growth factor

4.2 Epidermal growth factor

4.3 Platelet-derived growth factor

10 - Biosensors used in diabetes management

2. Diabetes mellitus: a 21st-century challenge

3. Biomarkers for diabetes

3.1 Glucose

3.2 Insulin

3.3 Exhaled breath acetone

3.4 Mannose

3.5 Circulating MicroRNAs

3.6 α-hydroxybutyric acid

4. Biosensors used in diabetes

4.1 History

4.2 Nanobiosensors for glucose detection

4.3 Biosensors for insulin

4.3.1 Label-free insulin biosensors

4.3.2 Sandwich-type electrochemiluminescent (ECL) biosensors

4.3.3 Aptamer-based electrochemical biosensors

4.4 Transdermal amperometric glucose biosensors

4.5 Microneedle-based glucose sensor platform

5. Hurdles for diabetes biosensors

6. Commercial biosensors

7. Conclusion

11 - Biosensors for cardiovascular applications

1. Introduction about cardiac diseases and their mortality rates

2. Cardiac biomarkers: guidelines and categories

2.1 Established cardiac-specific biomarkers

2.1.1 Established biomarker utility for acute coronary syndrome and myocardial infarction

2.1.2 Established biomarker utility for heart failure

2.1.3 Established biomarker utility for risk prognostication in a chronic stage

2.2 Emerging cardiac biomarkers

2.3 Cardiac biomarkers that provide add-on value for cardiovascular disease

2.4 Multiplex panels of cardiac biomarkers and their clinical benefits

3. An overview of sensing technologies for cardiovascular disease

3.1 Biosensors

3.1.1 Colorimetric multiplexed biosensors

3.1.2 Fluorescence multiplexed biosensors

3.1.3 Electrochemical and photoelectrochemical multiplexed biosensors.

3.1.4 Chemiluminescence and electrochemiluminescence multiplexed sensors.

Notes:

Description based on publisher supplied metadata and other sources.

Part of the metadata in this record was created by AI, based on the text of the resource.

ISBN:

9780443215933

0443215936

OCLC:

1492948930